This cohort of patients was a low-risk group since the patients had an average tumor size of 12.02 mm (range: 0.2–35 mm), half of them were grade 2, whereas 2.1% and 15.3% showed elevated HER2/neu and Ki67, respectively. The gene discussed is ERBB2; the disease is neoplasm.